Europe High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application (Dermatology, Uterine Fibroids, Prostate Cancer, Essential Tremor, Breast Cancer, Glaucoma, Backpain, Facetogenic, and Others), By Country and Growth Forec

Europe High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application (Dermatology, Uterine Fibroids, Prostate Cancer, Essential Tremor, Breast Cancer, Glaucoma, Backpain, Facetogenic, and Others), By Country and Growth Forecast, 2024 - 2031

The Europe High Intensity Focused Ultrasound Market would witness market growth of 6.8% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe High Intensity Focused Ultrasound Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $122.2 million by 2031. The UK market is experiencing a CAGR of 5.8% during (2024 - 2031). Additionally, The France market would exhibit a CAGR of 7.7% during (2024 - 2031).

HIFU provides a non-surgical solution for managing uterine fibroids. By targeting fibroid tissues with focused ultrasound, HIFU induces necrosis and shrinkage of fibroids, reducing symptoms such as heavy menstrual bleeding and pelvic pain. HIFU is used to treat endometriosis by targeting and ablating endometrial lesions. This application offers a minimally invasive alternative to traditional surgical treatments for endometriosis.

Also, in pain management, HIFU treats chronic pain conditions such as back pain and arthritis. By targeting nerve tissues or pain-generating structures with focused ultrasound, HIFU can relieve pain and improve the quality of life for patients suffering from chronic pain conditions. HIFU can be employed in pain management for localized nerve ablation, targeting specific nerves responsible for chronic pain and providing long-lasting relief.

The increasing cases of breast cancer across Europe drive the adoption of HIFU technology in various countries. This trend encourages the development of specialized HIFU clinics and integration into existing healthcare systems across the continent. As breast cancer rates rise, European countries may prioritize innovative treatments like HIFU in national healthcare policies and cancer treatment guidelines, potentially leading to better coverage and reimbursement. According to the European Commission, 374,800 women are estimated to be diagnosed with breast cancer in 2022. 95,800 women are estimated to die of breast cancer in 2022. Increased breast cancer cases stimulate more clinical trials and studies within Europe to explore the efficacy of HIFU in treating breast cancer, leading to improved clinical evidence and validation. Thus, the increasing number of breast cancer cases in the region is driving the growth of the market.

Based on Application, the market is segmented into Dermatology, Uterine Fibroids, Prostate Cancer, Essential Tremor, Breast Cancer, Glaucoma, Backpain, Facetogenic, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• >EDAP TMS S.A
• Sonablate Corp.
• Verasonics, Inc.
• ALPINION MEDICAL SYSTEMS Co., Ltd.
• Theraclion
• Lynton Lasers Ltd
• ULTRAISER
• PROFOUND MEDICAL CORP.

Europe High Intensity Focused Ultrasound Market Report Segmentation

By End Use

• >Hospital
• Imaging Centers
• Others

By Application

• >Dermatology
• Uterine Fibroids
• Prostate Cancer
• Essential Tremor
• Breast Cancer
• Glaucoma
• Backpain, Facetogenic
• Others

By Country

• >Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe